+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Surgical Robotics Market By Component (Systems, Accessories, Services), By Surgery Type (Gynecology Surgery, Urology Surgery, Neurosurgery, Orthopedic Surgery, General Surgery, Other Surgeries): Global Opportunity Analysis and Industry Forecast, 2023-2032

  • PDF Icon

    Report

  • 235 Pages
  • August 2023
  • Region: Global
  • Allied Market Research
  • ID: 4580628
The surgical robotics market was valued at $78.8 billion in 2022 and is estimated to reach $188.8 billion by 2032, exhibiting a CAGR of 9.1% from 2023 to 2032. Surgical robotics refers to the robotic systems that assist or perform surgical procedures. These systems are designed to enhance the capabilities of surgeons by providing precision, stability, and additional tools during surgeries. Surgical robotics has the potential to revolutionize the field of surgery by improving outcomes, reducing invasiveness, and enabling complex procedures that might otherwise be challenging for human surgeons. These systems are designed to work alongside human surgeons, enhancing their capabilities, and improving patient outcomes. Surgical robotics has gained significant attention and development over the years, with various applications in different surgical specialties.

The increase in need for automation in the healthcare sector and surge in demand for minimally invasive surgeries are the major factors that drive the surgical robotic market. In addition, rise in incidences of cancer, neurological disorders, gynecological diseases are anticipated to boost the adoption of robotic surgical systems. Surgical robotic systems offer less post-surgical complications and reduce labor cost. Large-scale hospitals based in developed and developing economies are now favoring automated surgical/hospital services due to this, which ultimately drives the market growth.

The surgical robotics market has experienced significant growth owing to the increase in demand for precision & minimally invasive surgical techniques. Surgical robots offer enhanced dexterity and accuracy, enabling surgeons to perform complex procedures through smaller incisions. This results in reduced trauma to the patient, less pain, quicker recovery times, and shorter hospital stays.

One of the primary driving factors for the surgical robotics market is the continuous advancement of technology. Robotic systems have evolved from basic telemanipulates to sophisticated platforms that offer enhanced dexterity, precision, and imaging capabilities. The integration of artificial intelligence (AI) and machine learning algorithms has further augmented the capabilities of surgical robots, enabling real-time data analysis and decision-making during procedures. These technological advancements have improved the accuracy of surgical interventions and expanded the scope of procedures that are performed robotically.

As surgical robots become more intelligent and capable, they enable surgeons to tackle increasingly complex and delicate surgeries with greater confidence and success rates, which supports the market growth. On the other hand, high cost associated with surgical robotics procedures and accidental death/injuries due to broken instruments and system errors are likely to hinder the market growth. However, the surge in R&D activities for developing innovative surgical robotic systems provides lucrative opportunity for market growth.

The surgical robotics market is segmented into component, surgery type, and region. By component, the market is segregated into systems, accessories, and services. By surgery type, the market is categorized into gynecology surgery, urology surgery, neurosurgery, orthopedic surgery, general surgery, and other surgeries. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East and Africa).

Major key players that operate in the surgical robotics market are Smith & Nephew plc, Medtronic plc, Stryker Corporation, Intuitive Surgical, Inc., Zimmer Biomet Holding Inc., Renishaw plc, Midea Group Co., Ltd., Johnson & Johnson, Accuray Incorporated, and CMR Surgical Ltd. The key players have adopted product launch and product approval as key developmental strategies to improve the product portfolio of the surgical robotics market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the surgical robotics market analysis from 2022 to 2032 to identify the prevailing surgical robotics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the surgical robotics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global surgical robotics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly update (only available with the purchase of an enterprise license)
  • 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
  • Free updated version (once released) with the purchase of a 1-5 or enterprise user license.
  • 16 analyst hours of support (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% free customization (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
  • Free data pack (Excel version) with the purchase of a 1-5 or enterprise user license.
  • Free report update, if the report is 6-12 months old or older.
  • 24-hour priority response
  • Free industry updates and white papers.

Key Market Segments

By Component

  • Systems
  • Accessories
  • Services

By Surgery Type

  • Gynecology Surgery
  • Urology Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • General Surgery
  • Other Surgeries

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East And Africa

Key Market Players

  • Smith & Nephew plc
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Accuray Incorporated
  • Zimmer Biomet Holding, Inc.
  • Stryker Corporation.
  • Midea Group Co., Ltd.
  • CMR Surgical Ltd.
  • Medtronic plc
  • Renishaw plc

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in occurrence of chronic diseases
3.4.1.2. Technological advancements and precision
3.4.1.3. Rise in demand for minimally invasive surgical procedures?
3.4.2. Restraints
3.4.2.1. High cost associated with surgical robotic systems and robotic surgeries
3.4.2.2. Lack of awareness among patients in emerging economies
3.4.3. Opportunities
3.4.3.1. Rise in R&D activities
3.4.3.2. Opportunities in emerging and untapped economies
CHAPTER 4: SURGICAL ROBOTICS MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Systems
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Accessories
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: SURGICAL ROBOTICS MARKET, BY SURGERY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Gynecology Surgery
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Urology Surgery
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Neurosurgery
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Orthopedic Surgery
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. General Surgery
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
5.7. Other Surgeries
5.7.1. Key market trends, growth factors and opportunities
5.7.2. Market size and forecast, by region
5.7.3. Market share analysis by country
CHAPTER 6: SURGICAL ROBOTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Component
6.2.3. Market size and forecast, by Surgery Type
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Component
6.2.4.1.2. Market size and forecast, by Surgery Type
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Component
6.2.4.2.2. Market size and forecast, by Surgery Type
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Component
6.2.4.3.2. Market size and forecast, by Surgery Type
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Component
6.3.3. Market size and forecast, by Surgery Type
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Component
6.3.4.1.2. Market size and forecast, by Surgery Type
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Component
6.3.4.2.2. Market size and forecast, by Surgery Type
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Component
6.3.4.3.2. Market size and forecast, by Surgery Type
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Component
6.3.4.4.2. Market size and forecast, by Surgery Type
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Component
6.3.4.5.2. Market size and forecast, by Surgery Type
6.3.4.6. Rest of Europe
6.3.4.6.1. Market size and forecast, by Component
6.3.4.6.2. Market size and forecast, by Surgery Type
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Component
6.4.3. Market size and forecast, by Surgery Type
6.4.4. Market size and forecast, by country
6.4.4.1. Japan
6.4.4.1.1. Market size and forecast, by Component
6.4.4.1.2. Market size and forecast, by Surgery Type
6.4.4.2. China
6.4.4.2.1. Market size and forecast, by Component
6.4.4.2.2. Market size and forecast, by Surgery Type
6.4.4.3. India
6.4.4.3.1. Market size and forecast, by Component
6.4.4.3.2. Market size and forecast, by Surgery Type
6.4.4.4. Australia
6.4.4.4.1. Market size and forecast, by Component
6.4.4.4.2. Market size and forecast, by Surgery Type
6.4.4.5. South Korea
6.4.4.5.1. Market size and forecast, by Component
6.4.4.5.2. Market size and forecast, by Surgery Type
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Component
6.4.4.6.2. Market size and forecast, by Surgery Type
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Component
6.5.3. Market size and forecast, by Surgery Type
6.5.4. Market size and forecast, by country
6.5.4.1. Latin America
6.5.4.1.1. Market size and forecast, by Component
6.5.4.1.2. Market size and forecast, by Surgery Type
6.5.4.2. Middle East And Africa
6.5.4.2.1. Market size and forecast, by Component
6.5.4.2.2. Market size and forecast, by Surgery Type
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Players
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Smith & Nephew plc
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Medtronic plc
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Stryker Corporation.
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.4. Intuitive Surgical, Inc.
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. Renishaw plc
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Zimmer Biomet Holding, Inc.
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Midea Group Co., Ltd.
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.8. Johnson & Johnson
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Accuray Incorporated
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.10. CMR Surgical Ltd.
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio

Executive Summary

According to this report, the surgical robotics market was valued at $78.8 billion in 2022, and is estimated to reach $188.8 billion by 2032, growing at a CAGR of 9.1% from 2023 to 2032. The Surgical Robotics Market is likely to experience a significant growth rate of 9.1% from 2023-2032 owing to increase in demand for surgical robotic systems and accessories from medical devices and supplies sector

Robotic surgery is a form of minimally invasive surgery where surgeons employ small surgical instruments that are introduced into the patient's body through a sequence of tiny incisions. These robotic systems provide enhanced precision, flexibility, and control during surgeries, ultimately improve patient outcomes and minimize invasiveness. The technology allows surgeons to operate with greater accuracy and dexterity, often using minimally invasive techniques that involve smaller incisions and reduced tissue damage.

Key factors driving the growth of the surgical robotics market include the rise in the occurrence of chronic diseases, rise in technological advancements, and increase in demand for minimally invasive surgical procedures chronic diseases are long-term medical conditions that require ongoing management and often involve complex treatments. Many chronic diseases, such as cardiovascular diseases, cancer, and orthopedic conditions, often require surgical interventions for diagnosis, treatment, or symptom management. For instance, according to the World Health Organization (WHO), 1.7 billion people had musculoskeletal conditions worldwide in 2022. Thus, the rise in prevalence of these conditions leads to a higher demand for surgical procedures.

In addition, increasingly prefer minimally invasive procedures due to their benefits, such as shorter hospital stays, reduced pain, and faster recovery times fuels the market growth. Surgical robotics enable surgeons to perform intricate procedures through smaller incisions, aligning with patient preferences for less invasive interventions which contribute toward the market growth. Patients increasingly seek procedures with reduced scarring, shorter recovery times, and fewer complications. Surgical robots enable minimally invasive interventions by providing surgeons with enhanced dexterity, visualization, and maneuverability. For instance, the Vinci Xi robotic system, manufactured by an Intuitive Surgical company, offers advanced minimally invasive solutions for various procedures, including urology, gynecology, and general surgery.

Furthermore, with the rise in robotics technology surgical robots have become more sophisticated, with improved accuracy, dexterity, and control. This led to a rise in demand for surgical robotics which fuels market growth. For instance, Smith & Nephew Plc. developed the CORI Surgical System with features such as image free smart mapping, more efficient, and expanded compatibility. As surgical procedures become increasingly complex and diverse, there is a growing demand for specialized instruments and tools that be seamlessly integrated with robotic platforms. These accessories, such as advanced instruments with intricate articulation and electrosurgical tools for precise tissue manipulation, enable surgeons to perform intricate tasks with greater precision and control thereby drive the market growth.

The market also offers growth opportunities to the key players in the market. The rapid advancement in surgical robotics owing to the increase in emphasis on research and development activities within the medical technology sector has provided the opportunity for market growth. The surge in research and development efforts has played a pivotal role in driving innovation, refining existing technologies, and ultimately propelling the growth of the surgical robotics market. The rise in healthcare expenditure in developing economies would help the manufacturer to exploit untapped opportunities. Moreover, manufacturers collaborate with government hospitals to provide robotic surgical solutions in underdeveloped regions. In addition, emerging economies might have a higher prevalence of diseases and conditions that require specialized surgical interventions which further provide the lucrative opportunity to the market growth.

The surgical robotics market is segmented into component, surgery type, and region. On the basis of component, the market is categorized into systems, accessories, and services. On the basis of surgery type, it is categorized into gynecology surgery, urology surgery, neurosurgery, orthopedic surgery, general surgery, and other surgery. Region wise, it is analyzed across North America (the U. S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific ((Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East Africa).

The key players profiled in the study include Smith & Nephew plc, Medtronic plc, Stryker Corporation, Intuitive Surgical, Inc., Zimmer Biomet Holding Inc., Renishaw plc, Midea Group Co., Ltd., Johnson & Johnson, Accuray Incorporated, and CMR Surgical Ltd. The players in the market have been actively engaged in the adoption of various strategies such as product launch and product approval to remain competitive and gain an advantage over the competitors in the market. For instance, in May 2022, Auris Health, Inc., a subsidiary of Ethicon, Inc., a Johnson & Johnson MedTech company, announced that its MONARCH Platform received 510(k) clearance from the U. S. Food and Drug Administration (FDA) for endourological procedures.

Key Market Insights

By component, the services segment was the largest revenue contributor to the market and is estimated to reach $170.5 billion by 2032. However, systems segment is anticipated to grow at the highest CAGR of 13.4% during the forecast period.

By surgery type, the general surgery segment dominated the global market with a highest CAGR of 9.9% during the forecast period.

Based on region, North America garnered the largest revenue share in 2022, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 11.0% during the forecast period.

Companies Mentioned

  • Smith & Nephew plc
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Accuray Incorporated
  • Zimmer Biomet Holding, Inc.
  • Stryker Corporation.
  • Midea Group Co., Ltd.
  • CMR Surgical Ltd.
  • Medtronic plc
  • Renishaw plc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...